Seer, Inc. (California) (SEER)
2.03
+0.12
(+6.28%)
USD |
NASDAQ |
Sep 28, 16:00
2.03
0.00 (0.00%)
After-Hours: 17:45
Seer Research and Development Expense (TTM) : 37.55M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.55M |
| March 31, 2026 | 41.33M |
| December 31, 2025 | 43.87M |
| September 30, 2025 | 45.14M |
| June 30, 2025 | 47.31M |
| March 31, 2025 | 46.56M |
| December 31, 2024 | 45.98M |
| September 30, 2024 | 44.56M |
| June 30, 2024 | 43.32M |
| March 31, 2024 | 44.88M |
| December 31, 2023 | 47.28M |
| September 30, 2023 | 48.76M |
| Date | Value |
|---|---|
| June 30, 2023 | 47.52M |
| March 31, 2023 | 44.70M |
| December 31, 2022 | 41.39M |
| September 30, 2022 | 36.70M |
| June 30, 2022 | 33.27M |
| March 31, 2022 | 29.67M |
| December 31, 2021 | 25.56M |
| September 30, 2021 | 24.13M |
| June 30, 2021 | 21.40M |
| March 31, 2021 | 19.34M |
| December 31, 2020 | 17.54M |
| September 30, 2020 | 16.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Champions Oncology, Inc. | 9.346M |
| Medpace Holdings, Inc. | -- |
| Avantor, Inc. | -- |
| Personalis, Inc. | 56.12M |
| Adaptive Biotechnologies Corp. | 80.01M |